<DOC>
	<DOCNO>NCT01071577</DOCNO>
	<brief_summary>Background : - Bone marrow stromal cell ( BMSCs ) grow bone marrow provide healthy volunteer . Volunteer bone marrow donor BMSCs generally require meet healthy history infectious disease marker screen criterion volunteer blood donor . BMSCs use treat number immune system cardiovascular disorder , include graft-versus-host disease ( GVHD ) , heart disease , vascular disease . The National Institutes Health Clinical Center interested collect bone marrow aspirate biopsy healthy volunteer produce clinical-grade BMSCs treat Clinical Center patient . - This study also collect bone marrow autologous donor ( donor later receive BMSCs ) treatment . Objectives : - To collect bone marrow aspirate biopsy healthy subject autologous donor order produce BMSCs . Eligibility : - Individuals least 18 year age either healthy volunteer individual need receive BMSCs . Design : - Prospective healthy volunteer ask series question design identify exposure human immunodeficiency virus ( HIV ) , hepatitis B C , transfusion-transmitted disease . A blood sample collect tested abovementioned disease problem may prevent bone marrow donation . - Prospective autologous donor also blood test evaluate suitability bone marrow donation . - Eligible participant schedule provide marrow aspirate/biopsy , take upper part thigh bone , use standard bone marrow donation technique . - The collected bone marrow process BMSCs National Institutes Health .</brief_summary>
	<brief_title>Collection Bone Marrow From Healthy Volunteers Patients Production Clinical Bone Marrow Stromal Cell ( BMSC ) Products</brief_title>
	<detailed_description>Bone marrow stromal cell ( BMSCs ) grow bone marrow aspirate biopsy , use treat number disorder include : graft-versus-host disease ( GVHD ) , ischemic heart disease , peripheral vascular disease autoimmune disease . The purpose protocol collect bone marrow aspirate biopsy healthy volunteer produce clinical grade BMSCs treat Clinical Center patient develop new method produce assess quality BMSCs . In case , donor recipients ex vivo expand cell ( autologous transplantation ) . In case , match HLA antigen require marrow donor BMSC recipient , donor require meet healthy history infectious disease marker screen criterion volunteer blood donor . The BMSCs produce GMP Clinical Cell Processing Laboratory , locate Cell Processing Section ( CPS ) , Department Transfusion Medicine ( DTM ) , Clinical Center . After BMSCs produce Cell Processing Laboratory , infuse directly Clinical Center patient protocol , cryopreserved store , use need treat Clinical Center patient . Up 250 subject enrol study . This protocol provide mechanism banking fresh frozen BMSC product use patient care research . This treatment protocol . Subjects receive BMSC product enrol specific BMSC treatment protocol .</detailed_description>
	<criteria>INCLUSION CRITERIA RELATED OR THIRD PARTY DONORS ( ALLOGENEIC CELLS ) : Age great equal 18 year old Ability give inform consent Adequate clinical parameter ( follow ) : Afebrile ( temperature le 38 ( Infinite ) C ) Systolic blood pressure great 100 &amp; less than180 mmHg Diastolic blood pressure great 50 &amp; less 100 mmHg Heart rate 40100 beats/minute Females childbearing potential must negative pregnancy test one following : Be surgically sterile Be abstinent marrow collect Use oral contraceptive , form hormonal birth control Use intrauterine device ( IUD ) birth control Use ( ensure male partner ( ) use ( ) barrier contraception ( condom ) birth control INCLUSION CRITERIA AUTOLOGOUS DONORS Age great equal 18 year old Ability give inform consent Females childbearing potential must negative pregnancy test one following : Be surgically sterile Be abstinent marrow collect Use oral contraceptive , form hormonal birth control Use intrauterine device ( IUD ) birth control Use ( ensure male partner ( ) use ) barrier contraception ( condom ) birth control EXCLUSION CRITERIA RELATED OR THIRD PARTY DONORS ( ALLOGENEIC CELLS ) Medical history include follow : Thrombocytopenia blood dyscrasia Bleeding diathesis Antibiotic use within prior 48 hour History cancer History exposure transfusion transmit disease include HIV hepatitis B C define Standards Blood Banking Transfusion Services , American Association Blood Banks . Travel area malaria endemic define CDC ( www.cdc.gov/travel ) . At risk possible transmission CreuzefeldtJackob Disease ( CJD ) Variant CreuzefeldtJackob Disease ( vCJD ) describe FDA Guidance Industry , January 9 , 2002 , Revised Preventive Measures Reduce Possible Risk Transfusion CreuzefeldtJackob Disease ( CJD ) Variant CreuzefeldtJackob Disease ( vCJD ) Blood Blood Products If female , pregnant within past 6 week Febrile ( temperature great 38 ( Infinite ) C ) Systolic blood pressure le 100 great 180 mmHg Diastolic blood pressure le 50 great 100 mmHg Heart rate le 40 great 100 beats/minute Anemia , thrombocytopenia , leukopenia 1 . Hemoglobin level African American woman &lt; 11.5 grams/dL Other woman &lt; 12.0 grams/dL Men &lt; 12.5 grams/dL 2 . HCT African American woman &lt; 34 % Other woman &lt; 36 % Men &lt; 38 % 3 . Platelets le 150 x 10 ( 3 ) /microL 4 . Absolute neutrophil count le 1.0 x 10 ( 3 ) /microL Prolonged coagulation assay 1 . PT great 15.2 second 2 . PTT great 37.3 second Positive test blood borne pathogen ( require Standards Blood Banks Transfusion Services , American Association Blood Banks . The currently require test include antiHIV1/2 , antiHCV , AntiHTVLI/II , antiT . Cruzi , HBsAg , syphilis , molecular test West Nile virus , HCV HIV ) . Experiencing fever , malaise , anorexia , weight loss night sweat consistent active tuberculosis infection EXCLUSION CRITERIA AUTOLOGOUS DONORS Medical history include follow : Currently Pregnant Positive test antiHIV1/2 , antiHCV , HBsAg Active tuberculosis infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2, 2016</verification_date>
	<keyword>Bone Marrow Stromal Cells</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>Immune Modulation</keyword>
	<keyword>Tissue Regeneration</keyword>
	<keyword>Bone Marrow</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>